Study of BEBT-908 Combined With Drugs in the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
BeBetter Med Inc
BeBetter Med Inc
University of Washington
Weill Medical College of Cornell University
Gilead Sciences
National Cancer Institute (NCI)
Fox Chase Cancer Center
National Cancer Institute (NCI)
Roswell Park Cancer Institute